AU7637796A - Expression of active interferon beta 1 using recombinant rna replicons - Google Patents

Expression of active interferon beta 1 using recombinant rna replicons

Info

Publication number
AU7637796A
AU7637796A AU76377/96A AU7637796A AU7637796A AU 7637796 A AU7637796 A AU 7637796A AU 76377/96 A AU76377/96 A AU 76377/96A AU 7637796 A AU7637796 A AU 7637796A AU 7637796 A AU7637796 A AU 7637796A
Authority
AU
Australia
Prior art keywords
expression
interferon beta
recombinant rna
rna replicons
active interferon
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU76377/96A
Inventor
James Edwin Bailey
Wolfgang Andreas Renner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU7637796A publication Critical patent/AU7637796A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/565—IFN-beta
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/36011—Togaviridae
    • C12N2770/36111—Alphavirus, e.g. Sindbis virus, VEE, EEE, WEE, Semliki
    • C12N2770/36141—Use of virus, viral particle or viral elements as a vector
    • C12N2770/36143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Virology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AU76377/96A 1996-12-09 1996-12-09 Expression of active interferon beta 1 using recombinant rna replicons Abandoned AU7637796A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB1996/001394 WO1998026084A1 (en) 1996-12-09 1996-12-09 Expression of active interferon beta 1 using recombinant rna replicons

Publications (1)

Publication Number Publication Date
AU7637796A true AU7637796A (en) 1998-07-03

Family

ID=11004501

Family Applications (1)

Application Number Title Priority Date Filing Date
AU76377/96A Abandoned AU7637796A (en) 1996-12-09 1996-12-09 Expression of active interferon beta 1 using recombinant rna replicons

Country Status (2)

Country Link
AU (1) AU7637796A (en)
WO (1) WO1998026084A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6015686A (en) 1993-09-15 2000-01-18 Chiron Viagene, Inc. Eukaryotic layered vector initiation systems
US6451592B1 (en) 1996-04-05 2002-09-17 Chiron Corporation Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis
EP0984062A1 (en) * 1998-09-04 2000-03-08 Cytos Biotechnology AG Production of human erythropoietin
US8647864B2 (en) 1999-04-14 2014-02-11 Novartis Ag Compositions and methods for generating an immune response utilizing alphavirus-based vector systems
DE60135983D1 (en) 2000-05-31 2008-11-13 Novartis Vaccines & Diagnostic PROCESS FOR CLEANING ALPHAVIRAL REPLICANT PARTICLES

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL102929A (en) * 1992-08-24 1996-11-14 Interpharm Lab Ltd Serum-free medium for mammalian cells
EP0733100A1 (en) * 1994-09-09 1996-09-25 Wolfgang A. Renner Chemical process for promoting the proliferation of animal cells

Also Published As

Publication number Publication date
WO1998026084A1 (en) 1998-06-18

Similar Documents

Publication Publication Date Title
AU685356B2 (en) Interferon solution
AU3104295A (en) Formulations for delivery of osteogenic proteins
AU3196195A (en) Muteins of mammalian cytokines
AU4008495A (en) Tcl-1 gene and protein and related methods and compositions
HUP0000829A2 (en) Stable liquid interferon formulations
AU4165993A (en) Aminediol compounds and derivatives and halohydrin intermediates
AU2215995A (en) Freeze-dried compositions comprising rna
AU2548097A (en) Formulations of ob protein
EP0822834A4 (en) Recombinant (beta)-cell and uses thereof
AU2380595A (en) Biologically active composition
GB9306386D0 (en) Gene expression
AU4628993A (en) Physiologically active peptide composition
AU8165298A (en) Cardiotrophin-like cytokine
AU5142293A (en) Somatotropin modifications
AU7637796A (en) Expression of active interferon beta 1 using recombinant rna replicons
AU4723297A (en) Oral preparations containing biologically active crystallized glass
AU6272490A (en) Biologically active compositions
HUP0600457A2 (en) 14alpha, 17alpha-c2-bridged 19-nor-progesterone derivatives, pharmaceutical compositions thereof and intermediates
AU2168795A (en) Recombinant Gibberellin DNA and uses thereof
GB9402189D0 (en) Biologically active formulations
NZ277605A (en) Human stanniocalcin-alpha polypeptide and dna (rna) encoding polypeptide; polypeptide may be derived from atcc 75861
AU3330497A (en) Human interleukin 12 gene expression regulating sequences
AU3928193A (en) Plasmilar gene, peptide and methods of use
AU7462191A (en) Gene expression
AU4955096A (en) Novel gene recombinant